medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2010, Number 591

<< Back Next >>

Rev Med Cos Cen 2010; 67 (591)

Fibromialgia

Rigg BJ, Calvo TO

Language: Spanish
References: 11
Page: 93-96
PDF size: 290.73 Kb.


ABSTRACT

Fibromyalgia is officially recognized by the World Health Organization as a non specialized rheumatic illness, because it presents no lesional patterns. Its etipatogenia is unknown because there are no complementary or radiological tests which demonstrate its existence. Because of this fact, the diagnosis is based on the clinical antecedents and a physical examination of the patient. In 1997, Goldberg and Cols. investigated on the possible causes of the syndrome without obtaining conclusive results, but they maintained the idea that it was a multifactorial process (neurological, viral agents, problems in transmission and modulation of painful stimulus) with psycho-social consequences. Investigations have showed the existence of biochemical, neuroendocrine, muscular and psychological anomalies associated to fibromyalgia. The effectiveness of the intervention is based on a multidisciplinary treatment: use of medicines, physical activity, massage, stretching, postural hygiene and psychological intervention.


REFERENCES

  1. Fernández RMA. Tratamiento de la fibromialgia. Rev Esp Reumatol 2000; 27:10.

  2. Gelmans SM, Lera S. Caballero F, López MJ. Tratamiento multidisciplinario de la fibromialgia. Estudio piloto prospectivo controlado. Rev Esp Reumatol 2002;29(7):323-9.

  3. Goldenberg DL. Differential diagnosis of fibromyalgia. 2005 Up To Date. Version 13.3. August 2005.

  4. Fauci, Braunwald, Kasper, Hauser, Longo, Jamenson, Loscalzo. Principios de Medicina Interna. Harrison, 17a edición, Mc Graww-Gill, 2009, página 2175-2177.

  5. MOIOLI, B. y MERAYO, L. A. Efectos de la intervención psicológica en dolor y el estado emocional de personas con fibromialgia. Rev. Soc. Esp. Dolor. 2005, vol. 12, no. 8, pp. 476-484.

  6. Rizzi M, Sarzi-Puttin P, Atzeni F, et al. Cyclic alternating pattern : A new marker of sleep alteration in patients with fibromyalgia. J Rheumatol 2004; 31: 1193-1199.

  7. RODRIGUEZ-HERNANDEZ, J. L. Dolor osteomuscular y reumatológico. Rev. Soc. Esp. Dolor. 2004, vol. 11, no. 2 [citado 2009-05-31], pp. 56-64.

  8. Spaeth M, Briley M. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Hum Psychopharmacol. 2009 May 28;24(S1):S3-S10.

  9. Uceda J, González A, Fernández C, Hernández R. Fibromialgia: aspectos históricos, definición y clasificación. Rev Esp Reumatol 2000;27:10; 414 -6.

  10. VILLANUEVA, V. L., VALIA, J. C., CERDA, G. et al. Fibromialgia: diagnóstico y tratamiento. El estado de la cuestión. Rev. Soc. Esp. Dolor.2004, vol. 11, no. 7, pp. 50-63.

  11. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994;23:255-9.




2020     |     www.medigraphic.com